Effect of FTY720, a novel immunosuppressant, on adjuvant- and collagen- induced arthritis in rats

International Journal of Immunopharmacology

Volumn 22, Issue 4, 2000, Pages 323-331

  Matsuura, Mamoru ^a   Imayoshi, Tomonori ^a   Okumoto, Takeki ^a  

^a Yoshitomi Pharmaceutical Industries Ltd   (Japan)

Author keywords

Adjuvant induced arthritis; Collagen induced arthritis; FTY720; Mizoribine; Peripheral lymphocyte; Prednisolone

Indexed keywords

ANTIRHEUMATIC AGENT; COLLAGEN; COLLAGEN ANTIBODY; FINGOLIMOD; IMMUNOSUPPRESSIVE AGENT; MIZORIBINE; PREDNISOLONE;

ADJUVANT ARTHRITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY BLOOD LEVEL; ARTHRITIS; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; LYMPHOCYTE COUNT; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; WEIGHT GAIN;

ANIMALS; ARTHRITIS, EXPERIMENTAL; COLLAGEN; DOSE-RESPONSE RELATIONSHIP, DRUG; IMMUNOSUPPRESSIVE AGENTS; MALE; PREDNISOLONE; PROPYLENE GLYCOLS; RATS; RATS, INBRED LEW; RATS, SPRAGUE-DAWLEY; RIBONUCLEOSIDES; SPHINGOSINE;

EID: 0033969361     PISSN: 01920561     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0192-0561(99)00088-0     Document Type: Article

References (27)

1. Adachi K., Kohara T., Nakao N., Arita M., Chiba K., Mishina T., Sasaki S., Fujita T. Design, synthesis and structure-activity relationships of 2-substituted-2-amino-1,3-propanediols: discovery of a novel immunosuppressant, FTY720. Bioorg. Med. Chem. Lett. 5:1995;853-856.
2. Badger A.M., Swift B.A., Webb E.F., Clark R.K., Bugelski P.J., Griswold D.E. Beneficial effects of SK&F 105685 in rat adjuvant arthritis: prophylactic and therapeutic effects on disease parameter progression. Int. J. Immunopharmac. 15:1993;343-352.
3. + T cells. Cell. Immunol. 144:1992;347-357.
4. Billingham M.E., Hicks C., Carney S. Monoclonal antibodies and arthritis. Agents Actions. 29:1990;77-87.
5. Bradbeer J.N., Kapadia R.D., Sarkar S.K., Zhao H., Stroup G.B., Swift B.A., Rieman D.J., Badger A.M. Disease-modifying activity of SK&F 106615 in rat adjuvant-induced arthritis. Arthritis Rheum. 39:1996;504-514.
6. Cannon G.W., McCall S., Cole B.C., Griffiths M.M., Radov L.A., Ward J.R. Effects of indomethacin, cyclosporin, cyclophosphamide and placebo on collagen-induced arthritis of mice. Agents Actions. 29:1990;315-323.
7. Chiba K., Hoshino Y., Suzuki C., Masubuchi Y., Yanagawa Y., Ohtsuki M., Sasaki S., Fujita T. FTY720, a novel immunosuppressant possessing unique mechanisms. I. prolongation of skin allograft survival and synergistic effect in combination with cyclosporine in rats. Transplant Proc. 28:1996;1056-1059.
8. Chiba K., Yanagawa Y., Masubuchi Y., Kataoka H., Kawaguchi T., Ohtsuki M., Hoshino Y. FTY720, a novel immunosuppressant, induces sequestration of circulating mature lymphocytes by acceleration of lymphocyte homing in rats. I. FTY720 selectively decreases the number of circulating mature lymphocytes by acceleration of lymphocyte homing. J. Immunol. 160:1998;5037-5044.
9. Chu C.Q., Londei M. Induction of Th2 cytokines and control of collagen-induced arthritis by nondepleting anti-CD4 Abs. J. Immunol. 157:1996;2685-2689.
10. Day RO, Graham, GG, Williams KM, Champion GD, Jager J. Clinical pharmacology of non-steroidal anti-inflammatory drugs. In: Orme MCL'E, editor. Anti-rheumatic drugs. New York: Pergamon Press. 1990:137-87.
11. Engelhardt G., Homma D., Schnitzler C. Meloxicam: a potent inhibitor of adjuvant arthritis in the Lewis rat. Inflamm. Res. 44:1995;548-555.
12. Engvall E., Perlmann P. Enzyme-linked immunosorbent assay, ELISA. III. Quantitation of specific antibodies by enzyme-labeled anti-immunoglobulin in antigen-coated tubes. J. Immunol. 109:1972;129-135.
13. Franch A., Castellote M., Castell M. Blood lymphocyte subsets in rats with adjuvant arthritis. Ann. Rhum. Dis. 53:1994;461-466.
14. Fujita T., Inoue K., Yamamoto S., Ikumoto T., Sasaki S., Toyama R., et al. Fungal metabolites. Part 11. a potent immunosuppressive activity found in Isaria sinclairii metabolite. J. Antibiot. 47:1994;208-215.
15. Gao J.X., Issekutz A.C. The effect of ebselen on polymorphonuclear leukocyte migration to joints in rats with adjuvant arthritis. Int. J. Immunopharmac. 15:1993;793-802.
16. Gao J.X., Issekutz A.C. The effect of ebselen on T-lymphocyte migration to arthritic joints and dermal inflammatory reaction in the rat. Int. J. Immunopharmac. 16:1994;279-287.
17. Hoshino Y., Suzuki C., Ohtsuka M., Masubuchi Amano Y., Chiba K. FTY720, a novel immunosuppressant possessing unique mechanisms. II. long-term graft survival induction in rat heterotopic cardiac allografts and synergistic effect in combination with cyclosporine A. Transplant Proc. 28:1996;1060-1061.
18. Kameda H., Nakagami K. Effect of mizoribine on collagen-induced arthritis in mice. Jpn. J. Pharmacol. 70:1996;169-175.
19. Kirwan J.R. The effect of glucocorticoids on joint destruction in rheumatoid arthritis. N. Engl. J. Med. 333:1995;142-146.
20. Littler TR. Anti-rheumatic drugs. In: Orme MCL'E, editor. Anti-rheumatic drugs. New York: Pergamon Press, 1990:189-216.
21. Masubuchi Y., Kawaguchi T., Ohtsuki M., Suzuki C., Amano Y., Hoshino Y., Chiba K. FTY720, a novel immunosuppressant, possessing unique mechanisms. IV. Prevention of graft vs host reactions in rats. Transplant Proc. 28:1996;1064-1065.
22. Pelegri C., Paz Morante M., Castellote C., Castell M., Franch A. Administration of a nondepleting anti-CD4 monoclonal antibody (W3/25) prevents adjuvant arthritis, even upon rechallenge: parallel administration of a depleting anti-CD8 monoclonal antibody (OX8) does not modify the effect of W3/25. Cell. Immunol. 165:1995;177-182.
23. Popp P.T., Peddinghaus R.M. Antirheumatic drug profiles evaluated in the adjuvant arthritis of rats by multiparameter analysis. Agents Actions. 42:1994;50-55.
24. Sasaki S., Hashimoto R., Kiuchi M., Inoue K., Ikumoto T., Hirose R., Chiba K., Okumoto T., Fujita T. Fungal metabolites. Part 14. novel potent immunosuppressants, mycestericins, produced by Mycelia sterilia. J. Antibiot. 47:1994;420-433.
25. Shiokawa Y., Honma M., Shichikawa K., Miyamoto T., Hirose J., Nobunaga T., et al. Clinical effectiveness of mizoribine on rheumatoid arthritis: A double-blind comparative study using lobenzarit disodium as a standard drug. Jpn. J. Inflamm. 11:1991;375-396.
26. Suzuki S., Li X.-K., Shinomiya T., Enosawa S., Amemiya H., Amari M., Naoe S. The in vivo induction of lymphocyte apoptosis in MRL-lpr/lpr mice treated with FTY720. Clin. Exp. Immunol. 107:1997;103-111.
27. Weichman B.M., Chau T.T., Rona G. Histopathologic evaluation of the effects of etodolac in established adjuvant arthritis in rats:evidence for reversal of joint damage. Arthritis Rheum. 30:1987;466-470.